NEWS

Follow the accumulating evidence and observations that shape our view of health policy and obesity

Needed: New Primary Care Models for Obesity

May 26, 2022 — The need for new primary care models for obesity is plain. A recent systematic review tells us that primary care providers see it as difficult to discuss with patients, futile, rife with stigma, and more of a social problem. Thus it’s a low priority. But thoughtful people are seeking a way forward. Two contrasting views […]

The Dark Art of Pharmacy Benefit Managers

May 24, 2022 — Drug pricing has been getting a lot of attention for some time now, so it’s no surprise that the prices of obesity medicines would get attention, too. New medicines are coming, competition will be increasing, and one factor in that competition will be prices. The only way to get good value is to consider both […]

Fixing Food Deserts: Promising or Trivial Effects?

May 24, 2022 — It seems to be an article of faith. Millions of low-income Americans live in food deserts and it puts them at higher risk for obesity. That’s a prevalent narrative to explain the link between poverty and obesity. And thus, the narrative works its way into the interpretation of research on programs for fixing food deserts. […]

Targeting Food Cues for Weight Management

May 23, 2022 — As we explained yesterday, there’s quite a body of research on the food cues that surround us and keep prodding us to eat. Food marketing embeds itself deeply in our daily lives. We suspect it explains a lot about our obesogenic food environment. Yet changing that environment has proven to be quite a challenge. So […]

Food Cues in the Eat-More Food Environment

May 22, 2022 — Our food environment has changed to contribute to the rise in obesity over the last half century. People disagree about many things in the effort to find policies to reduce obesity. But this presumption is one that most of us can agree upon. The real question, though, is how to define these changes. Are ultra-processed […]

Tirzepatide Pricing Comes in Similar to Semaglutide

May 21, 2022 — Competition can be a great thing. In the past few weeks we’ve been hearing a lot about tirzepatide. The FDA just approved it for treating type 2 diabetes, hailing it as an important advance. Tirzepatide for obesity is a couple of years away, but the initial results of pivotal studies have been extremely impressive. So […]

No, You’re Not Entitled to Your Opinion

May 20, 2022 — Authored by Patrick Stokes, Associate Professor of Philosophy, Deakin University Every year, I try to do at least two things with my students at least once. Firstly, I make a point of addressing them as “philosophers” – a bit cheesy, but hopefully it encourages active learning. Secondly, I say something like this: “I’m sure you’ve […]

A Suggestion That Diets for the Environment Are Rising

May 19, 2022 — It’s always interesting to see what surfaces in the annual Food Insight survey on food and health. The latest edition came out yesterday. For years now, the whole idea of following diets has been at a low ebb. Diets were supposed to be dead and buried years ago. Anti-diet dietitians are still dancing on that […]

How BMI Can Miss Unhealthy Fat in the Liver

May 18, 2022 — One of the important complications of obesity is NAFLD – non-alcoholic fatty liver disease. Quite simply, this is a condition where unhealthy fat accumulates in the liver. It leads to inflammation and fibrosis, progressing to cirrhosis, liver cancer, or liver failure in severe cases. Often, it goes undetected until these more severe problems emerge. Because […]

British Obesity Strategy Goes Into a Tailspin

May 17, 2022 — The British strategy to reverse trends in the health effects of obesity is “falling apart.” So says the distinguished obesity expert Jamie Oliver. He’s a chef, a celebrity, and thus an authority on the complex mix of biological, social, and political science that defines the public health struggle with obesity. But despite his wishes to […]